Working… Menu

Feasibility and Safety of IMP321 for Advanced Stage Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03252938
Recruitment Status : Completed
First Posted : August 17, 2017
Last Update Posted : May 21, 2021
Information provided by (Responsible Party):
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 14, 2021
Actual Study Completion Date : April 14, 2021